SALE AND PURCHASE AGREEMENTSale and Purchase Agreement • October 24th, 2022 • BIMI International Medical Inc. • Wholesale-drugs, proprietaries & druggists' sundries • New York
This Sale and Purchase Agreement (this “Agreement”), dated as of October 19, 2022, is entered into by and among BIMI INTERNATIONAL MEDICAL INC. (“Parent”), CHONGQING GUANZAN TECHNOLOGY CO., LTD. (“Guanzan”), CHONGQING ZHUODA PHARMACEUTICAL CO., LTD. (“Zhuoda”), XIAOLIN LIU (“Liu”), XUSEN HE (“He”), DONG ZHANG (“Zhang”, together with Liu and He, the “Liu Group”), YE ZHANG (“Y Zhang”) and BO WANG (“Wang”, together with Y Zhang, the “Wang Group”). Each of Liu, He Zhang, Y Zhang and Wang may be referred to hereinafter individually as a “Holder” and collectively as the “Holders” or the “Buyer Group”. Each of the parties named above may be referred to hereinafter n as a “Party” and collectively as the “Parties.” Capitalized terms used, but not otherwise defined, herein shall have the meanings set forth in Annex I.
